Form 8-K - Current report:
SEC Accession No. 0001493152-24-001771
Filing Date
2024-01-09
Accepted
2024-01-09 07:30:25
Documents
42
Period of Report
2024-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39293
2 ex99-1.htm EX-99.1 24333
3 ex99-1_001.jpg GRAPHIC 177643
4 ex99-1_002.jpg GRAPHIC 444106
5 ex99-1_003.jpg GRAPHIC 323069
6 ex99-1_004.jpg GRAPHIC 355098
7 ex99-1_005.jpg GRAPHIC 420939
8 ex99-1_006.jpg GRAPHIC 242998
9 ex99-1_007.jpg GRAPHIC 470296
10 ex99-1_008.jpg GRAPHIC 348120
11 ex99-1_009.jpg GRAPHIC 340677
12 ex99-1_010.jpg GRAPHIC 335719
13 ex99-1_011.jpg GRAPHIC 263413
14 ex99-1_012.jpg GRAPHIC 437208
15 ex99-1_013.jpg GRAPHIC 256458
16 ex99-1_014.jpg GRAPHIC 380932
17 ex99-1_015.jpg GRAPHIC 348568
18 ex99-1_016.jpg GRAPHIC 384455
19 ex99-1_017.jpg GRAPHIC 313205
20 ex99-1_018.jpg GRAPHIC 231881
21 ex99-1_019.jpg GRAPHIC 283102
22 ex99-1_020.jpg GRAPHIC 293610
23 ex99-1_021.jpg GRAPHIC 253262
24 ex99-1_022.jpg GRAPHIC 298114
25 ex99-1_023.jpg GRAPHIC 181338
26 ex99-1_024.jpg GRAPHIC 279307
27 ex99-1_025.jpg GRAPHIC 310565
28 ex99-1_026.jpg GRAPHIC 354493
29 ex99-1_027.jpg GRAPHIC 225133
30 ex99-1_028.jpg GRAPHIC 313584
31 ex99-1_029.jpg GRAPHIC 400194
  Complete submission text file 0001493152-24-001771.txt   13005008

Data Files

Seq Description Document Type Size
32 XBRL SCHEMA FILE mtnb-20240109.xsd EX-101.SCH 3307
33 XBRL LABEL FILE mtnb-20240109_lab.xml EX-101.LAB 34240
34 XBRL PRESENTATION FILE mtnb-20240109_pre.xml EX-101.PRE 22375
36 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3352
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 24521725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)